Literature DB >> 31644316

LINC01410/miR-3619-5p/FOXM1 Feedback Loop Regulates Papillary Thyroid Carcinoma Cell Proliferation and Apoptosis.

Gang Wang1, Xin Wang2, Ying Jin3.   

Abstract

Backgrounds: Thyroid cancer (TC) is a prevalent type of cancer in endocrine system. Past decades have seen the rising mortality and morbidity of TC. Long noncoding RNAs are renowned modulators of cancer onset and progression as validated by mounting studies. Long intergenic non-protein coding RNA 1410 (LINC01410) has been suggested as tumor-promoting gene in colon cancer and gastric cancer, but its role in TC is elusive. This study investigated the impact and mechanism of LINC01410 in TC. Materials and
Methods: RT-qPCR and western blot were used to detect gene expression levels. Cell counting kit-8 (CCK-8) and ethynyl-2'-deoxyuridine (EdU) assays were used to determine proliferation. Caspase-3 activity assay was used to examine apoptosis. Intermolecular interaction was investigated by luciferase reporter assay and chromatin immunoprecipitation (ChIP) assay.
Results: We confirmed the elevation of LINC01410 expression in TC cells. Loss-of-function experiments indicated that LINC01410 knockdown suppressed proliferation and facilitated apoptosis in TC. Mechanism research illustrated that LINC01410 positively regulated forkhead box M1 (FOXM1) expression through targeting miR-3619-5p, and that FOXM1 in turn transcriptionally activated LINC01410. Rescue experiments validated that LINC01410 regulated TC proliferation and apoptosis through miR-3619-5p/FOXM1. Conclusions: This study demonstrated that LINC01410/miR-3619-5p/FOXM1 positive feedback loop regulated cell proliferation and apoptosis in TC, shedding a light on the molecular target identification and promising treatment improvement in TC.

Entities:  

Keywords:  FOXM1; LINC01410; miR-3619-5p; papillary thyroid carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31644316     DOI: 10.1089/cbr.2019.2854

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  8 in total

1.  LncRNA LINC01410 Induced by MYC Accelerates Glioma Progression via Sponging miR-506-3p and Modulating NOTCH2 Expression to Motivate Notch Signaling Pathway.

Authors:  Xinli Zhao; Fazheng Shen; Bo Yang
Journal:  Cell Mol Neurobiol       Date:  2021-03-13       Impact factor: 5.046

2.  LINC01410 Knockdown Suppresses Cervical Cancer Growth and Invasion via Targeting miR-2467-3p/VOPP1 Axis.

Authors:  Fengjuan Liu; Chuansong Wen
Journal:  Cancer Manag Res       Date:  2020-02-05       Impact factor: 3.989

3.  Long noncoding RNA LINC01410 promotes the tumorigenesis of neuroblastoma cells by sponging microRNA-506-3p and modulating WEE1.

Authors:  Jie Mi; Yang Han; Jin Zhang; Xiwei Hao; Maoqing Xing; Cong Shang
Journal:  Cancer Med       Date:  2020-09-04       Impact factor: 4.452

4.  LINC01410 accelerated the invasion and proliferation of osteosarcoma by sponging miR-3128.

Authors:  Quanxiao Xu; Limin He; Lei Ma; Lin Fan; Lihua Yan; Xulin Zhao; Yuanyuan Li
Journal:  Aging (Albany NY)       Date:  2020-12-19       Impact factor: 5.682

5.  LncRNA NEAT1 Knockdown Inhibits Retinoblastoma Progression by miR-3619-5p/LASP1 Axis.

Authors:  Xuedong Chen; Shiyong Zhao; Qingjun Li; Caicai Xu; Yongbin Yu; Hongyan Ge
Journal:  Front Genet       Date:  2020-11-17       Impact factor: 4.599

6.  Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.

Authors:  Qian Zhou; Juan Guo; Wenjie Huang; Xiaosi Yu; Chen Xu; Xinghua Long
Journal:  Mol Oncol       Date:  2020-05-24       Impact factor: 6.603

7.  Long Noncoding RNA LINC01410 Suppresses Tumorigenesis and Enhances Radiosensitivity in Neuroblastoma Cells Through Regulating miR-545-3p/HK2 Axis.

Authors:  Liping Mou; Lili Wang; Shaoming Zhang; Qinghua Wang
Journal:  Onco Targets Ther       Date:  2021-05-18       Impact factor: 4.147

8.  Long Non-Coding RNA LINC01410 Promoted Tumor Progression via the ErbB Signaling Pathway by Targeting STAT5 in Gallbladder Cancer.

Authors:  Lili Lu; Shilong Zhang; Zhengqing Song; Weiqi Lu; Zhiming Wang; Yuhong Zhou
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.